Effect of locally applied morphine in painful arterial ulcers: No consolation;Effect lokaal toegepaste morfine bij pijnlijke arteriële ulcera: Geen soelaas

Pharmaceutisch Weekblad

Volumn 140, Issue 37, 2005, Pages 1145-1148

  Jansen, M M P M ^a   Van Der Horst, J C ^b   Van Der Valk, P C M ^c   Kuks, P F M ^b   Van Sorge, A A ^b  

^a GGZ Midden Brabant   (Netherlands)

^b RIJNSTATE HOSPITAL   (Netherlands)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOXYMETHYLCELLULOSE; MORPHINE; OPIATE; PLACEBO;

ANALGESIA; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; HUMAN; PERIPHERAL ISCHEMIA; RANDOMIZED CONTROLLED TRIAL; SKIN ULCER; VISUAL ANALOG SCALE;

EID: 24944587546     PISSN: 00316911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Stein C. Peripheral mechanisms of opioid analgesia. Anesth Analg. 1993;76:182-94.
2. Stein C. The control of pain in peripheral tissue by opioids. N Engl J Med. 1995;325:1123-6.
3. Krajnik M, Finlay IG, Zylicz Z: Opioids affect inflammation and the immune system. Pain Reviews. 1998;5:147-54.
4. Stein C, Schäfer M, Machelska H. Attacking pain at its source: new perspectives on opioids. Nature Medicine. 2003;9(8):1003-8
5. Mousa SA, Zhang Q, Sitte N, et al. D-Endorphin-containing memory-cells and μ-opioid receptors undergo transport to peripheral inflamed tissue. J Neuroimmunol. 2001;115:71-8.
6. Stein C, Pfluger M, Yassouridis A, et al. No tolerance to peripheral morphine analgesia in presence of opioid expression in inflamed synovia. J Clin Invest. 1996;98:793-9.
7. Back IN, Finlay I. Analgesic effect of topical opioids on painful skin ulcers. J Pain Symptom Manage. 1995;10:493.
8. Krajnik M, Zylicz Z, Finlay I, et al. Potential uses of topical opioids in palliative care - report of 6 cases. Pain. 1999;80:121-5.
9. Krajnik M, Zylicz Z. Topical morphine for cutaneous cancer pain. Palliat Med. 1997;11:325.
10. Twillman RK, Long TD, Cathers TA, et al. Treatment of painful skin ulcers with topical opioids. J Pain Symptom Manage. 1999;17:288-92.
11. Katz J, Melzack R. Measurement of pain. Surg Clin North Am. 1999;79(2):231-52.
12. Flock P. Pilot study to determine the effectiveness of diamorphine gel to control pressure ulcer pain. J Pain Symptom Manage. 2003;25:547-54.
13. Zeppetella G, Paul J, Ribeiro MDC. Analgesic efficacy of morphine applied topically to painful ulcers. J Pain Symptom Manage. 2003;25:555-8.
14. Hocking G, Cousins MJ. Ketamine in chronic pain management. An evidence-based review. Anest Analg. 2003;97:1730-9.
15. Wall PD, Melzack R. Textbook of pain 4de ed. Edinburgh:Churchill Livingstone; 1999. p. 634-5, 828.
16. Bigliardi-Qi M, Sumanovski LT, Buchner, et al. Mu-opiate receptor and beta-endorphin expression in nerve endings and keratinocytes in human skin. Dermatology. 2004;209:. 183-9.
17. Bigliardi PL, Sumanovski LT, Buchner S, et al. Different expression of mu-opiate receptor in chronic and acute wounds and the effect of beta-endorphin on transforming growth factor beta type II receptor and cytokeratin 16-expression. J Invest Dermatol. 2003;120:145-52.
18. Vase L, Robinson ME, Verne GN, et al. The contributions of suggestion, desire, and expectation to placebo effects in irritable bowel syndrome patients. An empirical investigation. Pain. 2003;105(1-2):17-25.
19. Benedetti F, Pollo A, Lopiano L, et al. Conscious expectation and unconscious conditioning in analgesic, motor, and hormonal placebo/nocebo responses. J Neurosci. 2003;23(10):4315-23.